Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2023

Accounting Policies [Abstract]

Schedule of Cash and Cash Equivalents

The following table provides a reconciliation of cash, cash equivalents and restricted cash within the condensed consolidated balance sheets that sum to the total of the same on the condensed consolidated statement of cash flows (in thousands):

	March 31, 2023		December 31, 2022
Cash and cash equivalents	$	358,665	$	337,087
Restricted cash	6,141		6,139
Total cash, cash equivalents and restricted cash	$	364,806	$	343,226

Restrictions on Cash and Cash Equivalents

The following table provides a reconciliation of cash, cash equivalents and restricted cash within the condensed consolidated balance sheets that sum to the total of the same on the condensed consolidated statement of cash flows (in thousands):

	March 31, 2023		December 31, 2022
Cash and cash equivalents	$	358,665	$	337,087
Restricted cash	6,141		6,139
Total cash, cash equivalents and restricted cash	$	364,806	$	343,226

Schedule of Earnings Per Share, Basic and Diluted

The following table presents the calculation of basic and diluted net loss per share (in thousands, except shares and per share data):

	Three Months Ended March 31,
	2023		2022
Basic loss per share:
Loss from continuing operations	$	(83,368)	$	(128,363)
Less: net loss attributable to non-controlling interest	11		93
Loss from continuing operations available to common shareholders	(83,357)		(128,270)
Loss from discontinued operations, net of tax	(256)		(12,454)
Net loss attributable to common shareholders	$	(83,613)	$	(140,724)
Shares used in computation:
Weighted-average common shares outstanding	225,461,595		157,503,479
Basic and diluted loss per share from continuing operations	$	(0.37)	$	(0.81)
Basic and diluted loss per share from discontinued operations	$	—	$	(0.08)
Basic and diluted loss per share	$	(0.37)	$	(0.89)

Schedule of Antidilutive Securities Excluded from Computation of Earnings per Share

The following common share equivalents are excluded from the calculation of weighted average common shares outstanding because their inclusion would have been anti-dilutive:

	March 31,
	2023	2022
Warrants to purchase common stock	166,670	3
Stock options	15,463,698	16,004,772
Unvested restricted stock units	13,704,304	5,877,591
Convertible notes variable settlement feature	6,966,078	6,966,078
Total	36,300,750	28,848,444